Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Intellectual Property

9 Months Ended

May 31, 2020

9. Intellectual Property

The following is a list of US capitalized patents held by the Company

Issued Patent #	Patent Issuance Date	Patent Family
US 9,474,725 B1	10/25/2016	Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof
US 9,839,612 B2	12/12/2017
US 9,972,680 B2	05/15/2018
US 9,974,739 B2	05/22/2018
US 10,084,044 B2	09/25/2018
US 10,103,225 B2	10/16/2018
US 10,381,440	08/13/2019
US 10,374,036	08/06/2019

The Company also holds non-capitalized patents outside the US. A continuity schedule for capitalized patents is presented below:

	May 31			August 31
	2020			2019
	$			$
Balance – beginning		265,127			146,538
Addition		20,007			122,982
Amortization*		(4,264	)		(4,393	)
Balance – ending		280,870			265,127
*The patents are amortized over their legal life of 20 years.